226 related articles for article (PubMed ID: 35859295)
1. Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury.
Tang JL; Xin M; Zhang LC
Aging (Albany NY); 2022 Jul; 14(14):5855-5877. PubMed ID: 35859295
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV Protects Sepsis-induced Acute Kidney Injury by Attenuating Mitochondrial Dysfunction and Apoptosis in Renal Tubular Epithelial Cells.
Feng M; Lv J; Zhang C; Chen D; Guo H; Tu Y; Su L; Wang Z
Curr Pharm Des; 2022; 28(34):2825-2834. PubMed ID: 36056848
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury.
Xu J; Zhang Z; Ren D; Liu L; Xing H; Wang D; Wu Y; Zhang Y; Chen Q; Wang T
Phytomedicine; 2024 Mar; 125():155346. PubMed ID: 38237511
[TBL] [Abstract][Full Text] [Related]
4. Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K/AKT/AS160 pathway.
Lu R; Chen J; Liu B; Lin H; Bai L; Zhang P; Chen D; Li H; Li J; Pang Y; Zhou Y; Zhou J; Wu J
Phytother Res; 2020 Dec; 34(12):3236-3248. PubMed ID: 32726508
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV attenuates sepsis-induced intestinal barrier dysfunction via suppressing RhoA/NLRP3 inflammasome signaling.
Xie S; Yang T; Wang Z; Li M; Ding L; Hu X; Geng L
Int Immunopharmacol; 2020 Jan; 78():106066. PubMed ID: 31835087
[TBL] [Abstract][Full Text] [Related]
6. Saponin fraction from Astragalus membranaceus roots protects mice against polymicrobial sepsis induced by cecal ligation and puncture by inhibiting inflammation and upregulating protein C pathway.
Gao XH; Xu XX; Pan R; Li Y; Luo YB; Xia YF; Murata K; Matsuda H; Dai Y
J Nat Med; 2009 Oct; 63(4):421-9. PubMed ID: 19548065
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
[TBL] [Abstract][Full Text] [Related]
8. A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1/GSK-3β pathway.
Yu X; Xiao Q; Yu X; Cheng Y; Lin H; Xiang Z
J Ethnopharmacol; 2022 Oct; 297():115535. PubMed ID: 35840059
[TBL] [Abstract][Full Text] [Related]
9. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier.
Zhang X; Zhang F; Li Y; Fan N; Zhao K; Zhang A; Kang J; Lin Y; Xue X; Jiang X
J Transl Med; 2024 Apr; 22(1):406. PubMed ID: 38689349
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV reduces neuronal apoptosis and parthanatos in ischemic injury by preserving mitochondrial hexokinase-II.
Li Y; Yang Y; Zhao Y; Zhang J; Liu B; Jiao S; Zhang X
Free Radic Biol Med; 2019 Feb; 131():251-263. PubMed ID: 30502455
[TBL] [Abstract][Full Text] [Related]
12. Loganin Attenuates Septic Acute Renal Injury with the Participation of AKT and Nrf2/HO-1 Signaling Pathways.
Zhang J; Wang C; Kang K; Liu H; Liu X; Jia X; Yu K
Drug Des Devel Ther; 2021; 15():501-513. PubMed ID: 33603340
[TBL] [Abstract][Full Text] [Related]
13. Shikonin attenuates kidney tubular epithelial cells apoptosis, oxidative stress, and inflammatory response through nicotinamide adenine dinucleotide phosphate oxidase 4/PTEN pathway in acute kidney injury of sepsis model.
Peng Y; Li Y; Li H; Yu J
Drug Dev Res; 2022 Aug; 83(5):1111-1124. PubMed ID: 35417044
[TBL] [Abstract][Full Text] [Related]
14. Anemonin inhibits sepsis-induced acute kidney injury via mitigating inflammation and oxidative stress.
Liu D; Li L; Li Z
Biotechnol Appl Biochem; 2023 Dec; 70(6):1983-2001. PubMed ID: 37592376
[TBL] [Abstract][Full Text] [Related]
15. CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway.
Wang Y; Xi W; Zhang X; Bi X; Liu B; Zheng X; Chi X
Front Immunol; 2022; 13():1053754. PubMed ID: 36713420
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
Yang P; Zhou Y; Xia Q; Yao L; Chang X
Biol Pharm Bull; 2019 May; 42(5):721-727. PubMed ID: 30867343
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice.
Zhao P; Wang Y; Zeng S; Lu J; Jiang TM; Li YM
Immunopharmacol Immunotoxicol; 2015; 37(5):428-33. PubMed ID: 26376109
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV Protects Rat Cardiomyocytes from Hypoxia-Induced Injury by Down-Regulation of miR-23a and miR-92a.
Gong L; Chang H; Zhang J; Guo G; Shi J; Xu H
Cell Physiol Biochem; 2018; 49(6):2240-2253. PubMed ID: 30257251
[TBL] [Abstract][Full Text] [Related]
19. Research progress of astragaloside IV in the treatment of atopic diseases.
Yu S; Peng W; Qiu F; Zhang G
Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656
[TBL] [Abstract][Full Text] [Related]
20. Esculentoside A ameliorates cecal ligation and puncture-induced acute kidney injury in rats.
Sun G; Yang W; Zhang Y; Zhao M
Exp Anim; 2017 Oct; 66(4):303-312. PubMed ID: 28637971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
